| Trial ID: | L0672 |
| Source ID: | JPRN-UMIN000004462
|
| Associated Drug: |
Ezetimibe
|
| Title: |
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non-alcoholic fatty liver disease, diabetes mellitus, hyper LDL-cholesterolemia
|
| Interventions: |
the administration of ezetimibe, 10mg per day
|
| Outcome Measures: |
The rate of change in LDL-cholesterol level after 24 weeks from entry1) the rate of change of fat accumulation in liver by abdominal ultrasound<br>2) the rate of change of hepatic function test<br>3) the rate of change of glucose tolerance<br>4) the rate of change of serum lipid level other than LDL-cholesterol<br>5) the rate of change of inflammatory markers<br>6) the rate of change of oxidative stress markers<br>7) safety
|
| Sponsor/Collaborators: |
Geriatric Medicine, Osaka University Graduate School of Medicine
|
| Gender: |
All
|
| Age: |
Not applicableNot applicable
|
| Phases: |
Not applicable
|
| Enrollment: |
20
|
| Study Type: |
Interventional
|
| Study Designs: |
Single arm Non-randomized
|
| Start Date: |
01/11/2010
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005340
|
